SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001477932-22-007013
Filing Date
2022-09-19
Accepted
2022-09-19 06:23:27
Documents
98
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K/A flora_6k.htm   iXBRL 6-K/A 143749
2 UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS flora_ex991.htm   iXBRL EX-99.1 1011057
  Complete submission text file 0001477932-22-007013.txt   7029493

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA flora-20220630.xsd EX-101.SCH 110689
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE flora-20220630_lab.xml EX-101.LAB 409958
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flora-20220630_cal.xml EX-101.CAL 64835
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flora-20220630_pre.xml EX-101.PRE 369562
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flora-20220630_def.xml EX-101.DEF 225027
92 EXTRACTED XBRL INSTANCE DOCUMENT flora_6k_htm.xml XML 1440914
Mailing Address 365 BAY STREET, SUITE 800 TORONTO A6 M5H 2V1
Business Address 365 BAY STREET, SUITE 800 TORONTO A6 M5H 2V1 416-861-2267
Flora Growth Corp. (Filer) CIK: 0001790169 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-40397 | Film No.: 221249328
SIC: 2834 Pharmaceutical Preparations